Nir Debotton

798 total citations
10 papers, 642 citations indexed

About

Nir Debotton is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Nir Debotton has authored 10 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 3 papers in Pediatrics, Perinatology and Child Health and 2 papers in Molecular Biology. Recurrent topics in Nir Debotton's work include Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Nir Debotton is often cited by papers focused on Advanced Drug Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). Nir Debotton collaborates with scholars based in Israel. Nir Debotton's co-authors include Simon Benita, Oshrat Harush-Frenkel, Yoram Altschuler, Arik Dahan, Jean Kadouche, Yoram Soroka, Marina Frušić‐Zlotkin, Zvi Ben‐Zvi, Gershon Holcberg and Riad Agbaria and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Nir Debotton

10 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nir Debotton Israel 7 284 227 159 142 123 10 642
Ramin Sakhtianchi Iran 7 335 1.2× 232 1.0× 194 1.2× 113 0.8× 82 0.7× 8 608
Diti Desai Finland 17 290 1.0× 226 1.0× 328 2.1× 213 1.5× 84 0.7× 28 796
Otilia Koo United States 11 403 1.4× 254 1.1× 260 1.6× 184 1.3× 208 1.7× 16 882
Samuli Hirsjärvi France 15 310 1.1× 230 1.0× 211 1.3× 79 0.6× 139 1.1× 21 687
Flavio Dormont France 6 414 1.5× 304 1.3× 252 1.6× 99 0.7× 74 0.6× 10 757
Xiangrui Yang China 17 458 1.6× 294 1.3× 323 2.0× 137 1.0× 120 1.0× 35 782
Behrang Shiri Varnamkhasti Iran 12 430 1.5× 349 1.5× 349 2.2× 259 1.8× 78 0.6× 21 980
Jun F. Liang United States 17 238 0.8× 302 1.3× 187 1.2× 97 0.7× 111 0.9× 31 830
Qiaoli Wu China 11 305 1.1× 225 1.0× 264 1.7× 311 2.2× 129 1.0× 17 857
Wenya Su China 12 281 1.0× 267 1.2× 208 1.3× 100 0.7× 75 0.6× 28 592

Countries citing papers authored by Nir Debotton

Since Specialization
Citations

This map shows the geographic impact of Nir Debotton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Debotton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Debotton more than expected).

Fields of papers citing papers by Nir Debotton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nir Debotton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Debotton. The network helps show where Nir Debotton may publish in the future.

Co-authorship network of co-authors of Nir Debotton

This figure shows the co-authorship network connecting the top 25 collaborators of Nir Debotton. A scholar is included among the top collaborators of Nir Debotton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nir Debotton. Nir Debotton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Debotton, Nir, et al.. (2022). Enabling oral delivery of antiviral drugs: Double emulsion carriers to improve the intestinal absorption of zanamivir. International Journal of Pharmaceutics. 629. 122392–122392. 9 indexed citations
3.
Polachek, Hana, Nir Debotton, Valeria Feinshtein, et al.. (2018). The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts. Drug Design Development and Therapy. Volume 12. 4129–4138. 4 indexed citations
4.
Debotton, Nir, et al.. (2017). Dermal absorption behavior of fluorescent molecules in nanoparticles on human and porcine skin models. International Journal of Pharmaceutics. 524(1-2). 290–303. 5 indexed citations
5.
Debotton, Nir & Arik Dahan. (2016). Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms. Medicinal Research Reviews. 37(1). 52–97. 89 indexed citations
6.
Debotton, Nir, et al.. (2014). Enhanced cutaneous bioavailability of dehydroepiandrosterone mediated by nano-encapsulation. Journal of Controlled Release. 189. 65–71. 12 indexed citations
7.
Debotton, Nir & Arik Dahan. (2014). A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals. Drug Discovery Today. 19(9). 1322–1336. 12 indexed citations
8.
Debotton, Nir, et al.. (2009). A quantitative evaluation of the molecular binding affinity between a monoclonal antibody conjugated to a nanoparticle and an antigen by surface plasmon resonance. European Journal of Pharmaceutics and Biopharmaceutics. 74(2). 148–156. 21 indexed citations
9.
Debotton, Nir, et al.. (2008). Overcoming the formulation obstacles towards targeted chemotherapy: In vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticles. Journal of Controlled Release. 127(3). 219–230. 28 indexed citations
10.
Harush-Frenkel, Oshrat, Nir Debotton, Simon Benita, & Yoram Altschuler. (2006). Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochemical and Biophysical Research Communications. 353(1). 26–32. 459 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramin Sakhtianchi Breakdown of academic impact, for papers by Diti Desai Breakdown of academic impact, for papers by Otilia Koo Breakdown of academic impact, for papers by Samuli Hirsjärvi Breakdown of academic impact, for papers by Flavio Dormont Breakdown of academic impact, for papers by Xiangrui Yang Breakdown of academic impact, for papers by Behrang Shiri Varnamkhasti Breakdown of academic impact, for papers by Jun F. Liang Breakdown of academic impact, for papers by Qiaoli Wu Breakdown of academic impact, for papers by Wenya Su
Rankless by CCL
2026